Bellevue Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-14,800
| Closed | -$1.22M | – | 185 |
|
|
2022
Q1 | $1.22M | Sell |
14,800
-6,800
| -31% | -$559K | 0.01% | 142 |
|
|
2021
Q4 | $3.17M | Buy |
21,600
+2,700
| +14% | +$396K | 0.03% | 136 |
|
|
2021
Q3 | $3.34M | Buy |
18,900
+11,600
| +159% | +$2.05M | 0.03% | 138 |
|
|
2021
Q2 | $1.18M | Sell |
7,300
-2,500
| -26% | -$404K | 0.01% | 149 |
|
|
2021
Q1 | $1.68M | Sell |
9,800
-2,500
| -20% | -$428K | 0.02% | 147 |
|
|
2020
Q4 | $2.7M | Sell |
12,300
-5,500
| -31% | -$1.21M | 0.03% | 137 |
|
|
2020
Q3 | $2.96M | Hold |
17,800
| – | – | 0.04% | 136 |
|
|
2020
Q2 | $2.03M | Buy |
17,800
+1,900
| +12% | +$217K | 0.03% | 134 |
|
|
2020
Q1 | $1.22M | Sell |
15,900
-400
| -2% | -$30.7K | 0.02% | 139 |
|
|
2019
Q4 | $2.1M | Buy |
16,300
+400
| +3% | +$51.5K | 0.03% | 129 |
|
|
2019
Q3 | $1.24M | Sell |
15,900
-5,600
| -26% | -$436K | 0.02% | 135 |
|
|
2019
Q2 | $2.22M | Buy |
21,500
+7,000
| +48% | +$721K | 0.04% | 126 |
|
|
2019
Q1 | $1.06M | Sell |
14,500
-9,500
| -40% | -$696K | 0.06% | 126 |
|
|
2018
Q4 | $1.02M | Sell |
24,000
-1,000
| -4% | -$42.4K | 0.07% | 113 |
|
|
2018
Q3 | $1.18M | Sell |
25,000
-500
| -2% | -$23.6K | 0.07% | 123 |
|
|
2018
Q2 | $1.26M | Buy |
+25,500
| New | +$1.26M | 0.11% | 111 |
|